Targeting the Liver-Brain Axis with Hop-Derived Flavonoids Improves Lipid Metabolism and Cognitive Performance in Mice.

Ines L ParaisoJohana S RevelJaewoo ChoiCristobal L MirandaParnian LakChrissa KioussiGerd BobeAdrian F GombartJacob RaberClaudia S MaierJan F Stevens

Published in: Molecular nutrition & food research (2020)

These observations suggest that XN, DXN, and TXN may alleviate obesity-induced metabolic and neurocognitive impairments by targeting the liver-brain axis.

Keyphrases

high fat diet induced
white matter
resting state
insulin resistance
metabolic syndrome
weight loss
type diabetes
high glucose
cerebral ischemia
bipolar disorder
diabetic rats
cancer therapy
weight gain
fatty acid
drug induced
brain injury
physical activity
oxidative stress
body mass index